1. Rezolute, Inc.

    0 Comments Leave a Comment

    1-1 of 1
    1. Mentioned In 1 Articles

    2. Rezolute Appoints Nektar Therapeutics COO & CFO to Its Board of Directors

      Rezolute Appoints Nektar Therapeutics COO & CFO to Its Board of Directors
      REDWOOD CITY, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Rezolute or the Company)(OTCQB:RZLT), a biopharmaceutical company specializing in the development of innovative drug therapies for patients with metabolic diseases, announced today the appointment of Gil Labrucherie to its Board of Directors (Board) where he will serve as Chairman of the Audit Committee. Mr. Labrucherie is currently the Chief Operating Officer and Chief Financial Officer of Nektar Therapeutics...
      Read Full Article
    3. 1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content